Fig. 3From: Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer studySurvival analysis of subgroups. A. Kaplan-Meier curve for OS between HPD and non-HPD groups before PSM. B. Kaplan-Meier curve for PFS between HPD and non-HPD groups before PSM. C. Kaplan-Meier curve for OS between HPD and non-HPD groups after PSM. D. Kaplan-Meier curve for PFS between HPD and non-HPD groups after PSMBack to article page